Latest Operational Cash Flow News

Spectur Limited posted its strongest quarter of cash receipts in FY26, driven by new contracts and a major technology upgrade, while launching legal action over significant customer losses.

Aspermont Limited reported a 25% year-on-year revenue increase to A$4.5 million in Q3 FY26, achieving normalised EBITDA breakeven for the first time and marking its 40th consecutive quarter of subscription growth. The company’s Data & Intelligence platform advances with key contracts underway and non-subscription revenues surging.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.

Betr Entertainment reported its first positive operating cash flow since 2021 with $2.6 million in Q4 FY26, driven by improved customer engagement and promotional efficiency. The company enters FY27 with strong momentum, including over 15% turnover growth in July excluding World Cup effects and record Same Game Multi volumes.

Western Mines Group (ASX:WMG) has wrapped up its Phase 5 drilling at Mulga Tank, delivering standout nickel-cobalt-copper assays and securing a $250,000 government grant for a seismic survey. Post-quarter, a $2.74 million capital raise led by Lowell Resources Fund boosts its exploration firepower.

Synertec has locked in a $4 million contract to upgrade AGL’s national SCADA system, reinforcing its foothold in critical infrastructure technology as it forecasts up to 50% revenue growth in FY27.

BetMakers Technology Group delivered a robust Q4 FY26 with revenue rising 9.4% to $24.2 million and adjusted EBITDA nearly doubling to $4.5 million, driven by new commercial deals and operational efficiencies.

BLS Pharmaceuticals capped FY2026 with record quarterly revenue and operating cash flow, driven by international expansion and new supply agreements across regulated markets.

Resolute Mining reported Q2 2026 gold production of 45,192 ounces with steady operations, while Doropo construction progresses on schedule and the ABC Project's inferred resource grows to 3 million ounces.

Predictive Discovery reported a 33% increase in gold production to 64,026 ounces in Q2 2026, driven by Kiniero’s operational ramp-up and advancing development at the Bankan project.

Xenitra Limited (ASX:XEN) has turned around its cash flow in Q4 FY26, reporting positive operating cash flow of A$0.8 million driven by a leaner cost base and a shift towards higher-margin OTC medicines and blockchain-enabled OPAL tokenised sales.